Premium
Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals
Author(s) -
Bui Eric,
Orr Scott P.,
Jacoby Ryan J.,
Keshaviah Aparna,
LeBlanc Nicole J.,
Milad Mohammed R.,
Pollack Mark H.,
Simon Naomi M.
Publication year - 2013
Publication title -
human psychopharmacology: clinical and experimental
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.461
H-Index - 78
eISSN - 1099-1077
pISSN - 0885-6222
DOI - 10.1002/hup.2330
Subject(s) - escitalopram , extinction (optical mineralogy) , habituation , psychology , placebo , fear conditioning , conditioning , classical conditioning , citalopram , developmental psychology , psychiatry , anxiety , medicine , neuroscience , antidepressant , chemistry , mineralogy , alternative medicine , statistics , mathematics , pathology
Objective We aimed to examine whether pretreatment with escitalopram would be associated with reduced fear acquisition and enhanced extinction learning in a fear conditioning paradigm, compared with placebo. Methods Healthy volunteers were randomized in double‐blind fashion, to 14 days of escitalopram 10 mg/day ( n = 18) or placebo ( n = 20) prior to a classical fear conditioning paradigm. Results Although escitalopram was associated with a smaller skin conductance (SC) orienting response during habituation, no medication effects on fear acquisition were found. Escitalopram was associated with faster extinction of SC responses, compared with placebo, as revealed by a significant drug × conditioned stimulus × trial interaction for early extinction ( F (3, 30) = 3.26, p = 0.035) and late extinction ( F (3, 30) = 3.27, p = 0.035) trials. After adjustment for age, orienting response, and acquisition, results from linear contrast remained significant for early extinction ( F (1, 29) = 5.43, p = 0.027). Conclusions Escitalopram administered for 14 days prior to a fear conditioning paradigm did not influence acquisition of a conditioned fear response but did facilitate extinction learning. Impairments in extinction learning have been identified as a key component of posttraumatic stress disorder; our preliminary findings suggest that additional experimental and clinical studies assessing the efficacy of selective serotonin reuptake inhibitors for posttraumatic stress disorder prevention are warranted. Copyright © 2013 John Wiley & Sons, Ltd.